NICE recommends Consilient Health’s elmiron® for bladder pain syndrome
Consilient Health welcomes the decision by the National Institute for Health and Care Excellence (NICE) to recommend elmiron® (pentosan polysulfate sodium) for bladder pain...
AstraZeneca presents anifrolumab results from Phase III TULIP trial
Results from the positive Phase III TULIP 2 trial for AstraZeneca's anifrolumab, a potential new medicine for the treatment of moderate to severe systemic...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
NHS Commercial Framework for Medicines consultation published
NHS England has published the NHS Commercial Framework for Medicines for consultation. NHS England has a significant role to play in supporting patient access to...
Medopad and Janssen collaborate on novel digital biomarker for Alzheimer’s disease
Medopad has announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and...
New data on Roche haematology portfolio and pipeline
New data on the Roche haematology portfolio and pipeline is being presented at the American Society of Hematology 2019 Annual Meeting. Roche announced that...
Cytel acquires MTEK Sciences
Cytel acquires MTEK Sciences to further expand its advanced real-world analytics (RWA) capabilities. The acquisition of MTEK is the latest step in Cytel’s journey...
Oxford Drug Design wins UK-China antimicrobial resistance grant
Oxford Drug Design has won a UK-China antimicrobial resistance grant and also boosted its funding with investment from the Angel CoFund. Oxford Drug Design Limited...
EC approves BAVENCIO® combination for advanced kidney cancer
Merck and Pfizer have announced that the European Commission (EC) has approved BAVENCIO® (avelumab) in combination with axitinib for the first-line treatment of adult...
AstraZeneca divests rights to Seroquel and Seroquel XR in Europe and Russia
AstraZeneca has agreed the sale and licence of the commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release)...
Latest articles
Artelo Biosciences names Aptus Clinical as CRO partner
Aptus Clinical has been appointed full service clinical CRO partner by Artelo Biosciences Inc. (through their fully owned UK subsidiary, Trinity R&D Ltd). Aptus Clinical...
OKRA joins Veeva Technology Partnership Program
OKRA Technologies, a leading provider of Artificial Intelligence (AI) driven analytics for global life sciences, announced they are joining the Veeva Technology Partnership Program...
Adherium and Patients Know Best partnership for respiratory care data
Adherium and Patients Know Best® have announced a strategic partnership to enable access to respiratory care data in the UK. Adherium and Patients Know...
Popular articles
Replacing traditional brand management with multichannel interaction
Graham McIntosh, Managing Director of Commercial & Clinical Pharma, at Uniphar Group plc looks at how the traditional brand management approach isn’t working anymore...
Why are life science companies contracting market access activities?
Sathyanarayanan Krishnamurthy, Vice President – Regulatory Operations at Freyr Solutions looks at contracting out market access activities and how this frees up life sciences...
OKRA joins Veeva Technology Partnership Program
OKRA Technologies, a leading provider of Artificial Intelligence (AI) driven analytics for global life sciences, announced they are joining the Veeva Technology Partnership Program...
Adherium and Patients Know Best partnership for respiratory care data
Adherium and Patients Know Best® have announced a strategic partnership to enable access to respiratory care data in the UK. Adherium and Patients Know...
How essential is digital engagement with HCPs?
Liz Murray and Nicolas Laurent on how digital engagement is essential in today’s tech-driven landscape. But could life sciences companies be doing better? Engagement between...